Topic List : Cardiovascular Health
A baby with a mosaic heart
Researchers have solved the mystery of an infant with severe long QT syndrome, found to be caused by a lethal genetic defect in only 8 percent of her cells.
App for studying peripheral artery disease
Researchers hope people who have the condition will download the app and enroll in a study that will provide insights into patterns of the disease’s progression and may point toward new methods of treatment.
iPS cell-derived heart cells predict drug toxicity
Heart muscle cells made from induced pluripotent stem cells share gene expression patterns with native donor tissue, researchers discovered. These cells can be used to indicate people who should avoid certain medications that could damage their hearts.
Antibodies could counter atherosclerosis
A biological drug could be used to combat cardiovascular disease by targeting not mere risk factors such as high cholesterol or high blood pressure, but the actual lesions bearing direct responsibility: atherosclerotic plaques.
Five years of life with heart pump
Edgar Arredondo has lived with a ventricular assist device for longer than any other patient being treated at Lucile Packard Children’s Hospital Stanford.
Cardiologist Alfred Spivack dies at 87
Spivack, who founded the coronary care unit at Stanford, was an early champion of increasing nurses' role in caring for cardiology patients.
A lifesaving heart surgery
Swimming lessons? Check. Banging on the piano? Check. Playing in the snow? Check. Toddler Alex Bracebridge is now living a normal life, thanks to a heart surgery at Lucile Packard Children’s Hospital Stanford.
IPS cells aid study of chemotherapy side effect
Doxorubicin is a chemotherapy drug used to treat many cancers, but it causes serious heart damage in some patients. Heart muscle cells made from the skin cells of breast cancer patients can be used to study this phenomenon.
Transplant procedure saves two patients
Stanford Medicine surgeons performed an unusual transplantation in which one woman received a heart-lung transplant, while her existing heart was given to another patient.
MyHeart Counts app plugs in genetics
A phone app developed at Stanford to study heart disease risk and help ordinary people manage that risk has teamed up with 23andMe to add a genetics option.